Movement Disorders

Filter Your Results

 

News

 

Anti-Alpha-Synuclein Antibody Shows Early Potential as Parkinson’s DMT

Friday, June 09, 2017—PRX002, an investigational monoclonal antibody, may inhibit cell-to-cell transmission of alpha-synuclein and modify disease progression in Parkinson’s disease (PD), acco…

Tardive Dyskinesia: A New Treatment for an Old Disorder

Laxman Bahroo, DO and Rita Gandhy, MD, MPH

June 2017—A recently approved treatment can safely treat tardive dyskinesia without the need to alter a patient’s psychiatric medication.

Smartphone Sensor Data Offer Insights Into Daily Functioning in Patients with Parkinson’s Disease

Wednesday, June 07, 2017—Smartphones are a valuable resource in gaining mobility data in patients with Parkinson’s disease, according to new research presented at the 21st International Congress…

Neurodegenerative Diseases Linked by Abnormal Proteins Causing Similar Damage to Brain Cells

Tuesday, May 30, 2017—Abnormal proteins found in Alzheimer's disease, Parkinson's disease, and Huntington's disease share a similar ability to cause damage when they invade brain cells,…

Levodopa: 50 and Fabulous

Jill Giordano Farmer, DO, MPH

May 2017—The gold standard of Parkinson’s disease management has just entered its Golden jubilee. In the 1960s, Arvid Carlsson linked the depletion of striatal dopamine with Park…

AAN 2017 Meeting: New Evidence Suggest Parkinson’s Originates in the Gut

Wednesday, April 26, 2017—Parkinson’s disease may start in the gut and spread to the brain via the vagus nerve, according to a study published in the April 26, 2017, online issue of Neurology®…

Elekta: New Data on Stereotactic Neurosurgery Devices Presented at AANS

Monday, April 24, 2017—Elekta's Leksell Gamma Knife® radiosurgery system has been highlighted in more than 15 scientific presentations at the American Association of Neurological Surgeo…

First Treatment for Tardive Dyskinesia Approved in US

Wednesday, April 12, 2017—The FDA approved the selective VMAT2 inhibitor Ingrezza (valbenazine, Neurocrine Biosciences), making it the first treatment approved in the US to treat adults with tardive dy…

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in January 2002, Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.

 
  • BRYN MAWR COMMUNICATIONS III, LLC